In addition, other PCSKs, including PCSK6, appearto compensate for pro-insulin receptor processing in the absence offurin in the liver.68 Therefore, targetingfurin might not dramatically worsen comorbid hypertension and diabetes,although a reduction in furin is associated with the risk of thesediseases. Here, PCSK6 is linked to hypertensive disorder.